VAERS 2237206
GLAXOSMITHKLINE BIOLOGICALS · DTAP + IPV (KINRIX) · Charge Y297N
- Staat
- OR
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 16.04.2022
- Impfdatum
- 06.04.2022
- Beginn
- 06.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
a 3-year-old received Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old female patient who received DTPa-IPV (Kinrix) (batch number Y297N, expiry date 26th August 2022) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th April 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 6th April 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-Apr-2022 Reporter's Comments: The reporter stated that a 3-year-old patient received Kinrix. The reporter consented to follow-up. Additional Supportive Information: The reporter stated that a 3-year-old patient received Kinrix, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -